Bias, spin, and misreporting: time for full access ... [PLoS Med. 2008] - PubMed

loading

Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. [PLoS Med. 2008]
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.
Rising K, Bacchetti P, Bero L. PLoS Med. 2008 Nov 25; 5(11):e217; discussion e217.
Publication bias and the efficacy of antidepressants. [Am J Psychiatry. 2009]
Publication bias and the efficacy of antidepressants.
Mathew SJ, Charney DS. Am J Psychiatry. 2009 Feb; 166(2):140-5.
Publication of clinical trials supporting successful new drug applications: a literature analysis. [PLoS Med. 2008]
Publication of clinical trials supporting successful new drug applications: a literature analysis.
Lee K, Bacchetti P, Sim I. PLoS Med. 2008 Sep 23; 5(9):e191.
Review Hypothesis: a single clinical trial plus causal evidence of effectiveness is sufficient for drug approval. [Clin Pharmacol Ther. 2003]
Review Hypothesis: a single clinical trial plus causal evidence of effectiveness is sufficient for drug approval.
Peck CC, Rubin DB, Sheiner LB. Clin Pharmacol Ther. 2003 Jun; 73(6):481-90.
Review Muraglitazar and the FDA: what constitutes drug safety? [Prev Cardiol. 2006]
Review Muraglitazar and the FDA: what constitutes drug safety?
Liebson PR. Prev Cardiol. 2006 Spring; 9(2):110-4.

Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. [PLoS One. 2013]
Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.
Djulbegovic B, Kumar A, Miladinovic B, Reljic T, Galeb S, Mhaskar A, Mhaskar R, Hozo I, Tu D, Stanton HA, et al. PLoS One. 2013; 8(3):e58711. Epub 2013 Mar 21.
Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports. [BMJ Open. 2013]
Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports.
Doshi P, Jefferson T. BMJ Open. 2013; 3(2). Epub 2013 Feb 26.
Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment. [BMJ. 2013]
Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment.
Panagiotou OA, Contopoulos-Ioannidis DG, Ioannidis JP. BMJ. 2013 Feb 12; 346:f707. Epub 2013 Feb 12.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Bias, spin, and misreporting: time for full access to trial protocols and result...
Bias, spin, and misreporting: time for full access to trial protocols and results.
PLoS Med. 2008 Nov 25 ;5(11):e230. doi: 10.1371/journal.pmed.0050230.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed